INTRODUCTION
Iron is required for cellular processes such as electron transport and redox biochemistry. In its ferric oxidation state, iron is very insoluble at neutral pH, whereas in its ferrous form, uncomplexed iron can produce dangerous free radicals. Vertebrates store excess iron in ferritin, a protein that can store up to 4500 ferric atoms in its hollow core (reviewed in [1] ). Previous experiments have provided evidence that lysosomes can internalize and digest extracellular ferritin. Extracellular ferritin administered intravenously into rats is rapidly metabolized by hepatocytes [2] by a chloroquine-inhibitable process [1] . Subcellular localization experiments have also shown that hepatocytes incubated with extracellular &*Fe-labelled ferritin localize radioactivity to lysosomes [3] , although the mechanism by which this lysosomal iron is transported into the cytosol is unclear. Furthermore little is known about iron recycling from existing, cytosolic ferritin. It has been suggested that iron can be released directly from ferritin present in the cytosol by ascorbate [4] . An alternative mechanism involves intracellular transport of ferritin from the cytosol into the lysosome, followed by lysosomal degradation [5] . Consistently with this hypothesis, ferritin introduced into the cytosol of HeLa cells by microinjection [6] or liposome fusion [7] is transported to lysosomes. Additionally, serum deprivation of rat hepatocytes increases both the rate of lysosomal autophagy of cytosolic ferritin and the cellular free iron pool [8] .
Determining the mechanism of intracellular ferritin iron recycling has been hindered by the complexity of the ferritin\iron flux [9] . New ferritin molecules are constantly being synthesized and loaded with iron while the iron from existing ferritin molecules is being reused. We describe experiments that employ cationic ferritin (CF) to address the role of ferritin degradation in the iron reutilization pathway. These studies demonstrate that the lysosomal degradation of ferritin is one mechanism by which iron can be reutilized from the ferritin iron core.
EXPERIMENTAL

Cell culture and reagents
Human fibroblast (HF) cells [10] were grown in Earle's minimal essential medium supplemented with 10 % (v\v) fetal-bovine serum (growth medium). CF was purchased from Sigma (St.
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that cells can utilize lysosomal ferritin to produce increased cytosolic ferritin levels. Further, using an in itro assay, we showed that isolated lysosomes degrade endogenous ferritin in a time-and temperature-dependent manner. These results are consistent with a model in which cytosolic ferritin is taken into the lysosomes and degraded. The solubilized iron from the ferric core could then be transported across the lysosomal membrane back into the cytosol.
Louis, MO, U.S.A.), and was sterile-filtered before use. Unless indicated otherwise, all other enzymes and chemicals were also obtained from Sigma. For RIA analysis, cells were solubilized in 0.1 % (v\v) Triton X-100, then lysates were quantified with a ferritin RIA kit from Ramco Laboratories (Houston, TX, U.S.A.).
Measurement of endogenous ferritin and CF
For experiments investigating the dependence of ferritin levels on the time of exposure to CF, HF cells were exposed to 10 µg\ml CF in growth medium for the indicated times, then washed and incubated with growth medium for the remainder of the experiment. At the designated times, cells were solubilized in PBS containing 0.1 % (v\v) Triton X-100 ; lysates were then analysed for ferritin content by RIA. For experiments investigating the dependence of ferritin levels on CF concentration, cells were exposed to the indicated concentrations of CF in growth medium for 1 h, then washed and incubated with growth medium for the remainder of the experiment, and analysed as before. For the concurrent measurement of CF degradation and endogenous ferritin levels, cells were incubated for 60 min with 2 µg\ml CF in growth medium, then washed and reincubated with growth medium. Incubation was stopped at designated times, and samples were processed for RIA analysis as before. For the determination of CF degradation, lysates were subjected to electrophoresis on 10 % polyacrylamide gels, then Western blotted and probed with anti-(horse spleen ferritin) antibody (ICN, Aurora, OH, U.S.A.). For chelation experiments, cells were exposed to 10 µg\ml CF in growth medium alone or in growth medium supplemented with 2 mM bathophenanthroline sulphonate (BPS) or 2 mg\ml iron-free conalbumin, then washed and incubated with growth medium alone or growth medium supplemented with 2 mM BPS or 2 mg\ml iron-free conalbumin respectively.
Metabolic labelling and immunoprecipitation of ferritin
HF cells were treated with 10 µg\ml CF in growth medium for various durations, then washed and incubated in growth medium for 3 days. Cells were washed twice with PBS and pulsed for 1 h at 37 mC in methionine-free minimal essential medium supple-mented with [$&S]methionine (DuPont-NEN, Boston, MA, U.S.A.) to a concentration of 100 µCi\ml. Metabolically labelled cells were either immediately lysed in 0.1 % (v\v) Triton X-100 or incubated in growth medium for an additional time before lysis. Lysates were immunoprecipitated with rabbit anti-(human ferritin) antibody (ICN). The antigen-antibody complex was immobilized with Pansorbin (Calbiochem, La Jolla, CA, U.S.A.) and washed extensively. The beads were boiled for 5 min in 0.1 % (w\v) SDS and the supernatant was subjected to electrophoresis on 12 % polyacrylamide gels. After fixation the gels were soaked in Amplify (Amersham, Arlington Heights, IL, U.S.A.). The intensities of the ferritin bands were quantified by phosphorimager.
Effect of addition of ascorbate on ferritin synthesis and half-life
For the measurement of endogenous ferritin synthesis, cells were incubated for 4 h with 10 µg\ml CF in growth medium containing 0, 0.1 or 0.3 mM ascorbic acid, then washed and reincubated with growth medium alone or with growth medium supplemented with ascorbic acid. Incubation was stopped at designated time points (medium was refreshed daily) and cells were solubilized in 0.1 % (v\v) Triton X-100. For the degradation of endogenous ferritin, cells were incubated with 5 µg\ml CF for 1 h, then washed and reincubated with growth medium for 2 days. Cells were then labelled by incubation in methionine-free medium supplemented with 100 µCi\ml Tran$&S-label (ICN) for 2 h, then washed and reincubated with growth medium that contained either 0 or 0.3 mM ascorbic acid. Incubation was stopped at designated time points (medium was refreshed daily) and cells were solubilized in 0.1 % (v\v) Triton X-100. Samples were immunoprecipitated, subjected to electrophoresis and phosphorimaged as above.
Gradient fractionation and isolation of intact lysosomes
Procedures for gradient fractionation and lysosome isolation were optimized from previously published protocols [11] . For initial experiments, HF cells were either incubated in growth medium for 16 h or incubated for 1 h with 10 µg\ml CF in growth medium, then washed and incubated with growth medium for 16 h. For initial fractionation, four confluent 100 mm plates were scraped into 2 ml of STE buffer [0.25 M sucrose, 20 mM Tris\HCl (pH 7.2), 5 mM MgCl # ], and homogenized in a Dounce homogenizer. Homogenates were centrifuged at 800 g for 10 min and postnuclear supernatants were layered on 23 % (v\v) Percoll gradients, then centrifuged at 59 000 g for 27 min. The resultant gradient was fractionated ; fractions were assayed for hexosaminidase activity by using previously published procedures [12] , and for ferritin content by RIA. For lysosome isolation, ten confluent 75 cm# flasks were scraped into 2 ml of homogenization buffer, then fractionated as before. Lysosomal fractions identified by hexosaminidase activity (usually the first three fractions) were then pelleted [13] . Pellets were resuspended in STE buffer then incubated as indicated. Ferritin levels were measured by RIA ; results are the averaged values of duplicate samples. Unless indicated otherwise, all operations were performed at 0 mC. For incubation in the presence of ATP, the solution was supplemented with an ATP regeneration system (50 µM ATP\400 mM phosphocreatine containing 400 units\ml creatine kinase).
RESULTS
CF stimulates increased levels of endogenous ferritin
We hypothesize that iron, in endogenous cytosolic ferritin, can be recycled by a process that begins with intracellular transport to lysosomes and is followed by degradation to release the iron core. To test the possibility that cells can utilize iron released from lysosomally degraded ferritin, we monitored the response of HF cells when incubated with CF, which is a polycationic derivative of horse spleen ferritin [14] that has been used as an EM stain for membranes and to study membrane endocytosis. CF adheres to negative charges on cell surfaces, is non-specifically endocytosed and is then concentrated in lysosomes [15] . Its subsequent metabolism has not been previously pursued. If iron released from CF degraded in the lysosome is metabolically available to the cell, then treatment of cells with CF should produce an increased translation of new ferritin molecules, with accompanying increases in endogenous ferritin levels. It might also be that incubation with CF suppresses the degradation of endogenous ferritin ; this effect might contribute to increased ferritin levels as well. Endogenous ferritin levels can easily be measured by RIA with an antibody against human ferritin. With this procedure, the horse spleen-derived CF was found to be immunologically distinct. When samples of human ferritin, horse ferritin and CF were measured with the RIA kit, only human ferritin produced a measurable signal (Figure 1) .
When HF cells were exposed to CF, endogenous ferritin levels were increased from background levels of approx. 50 ng of ferritin\µg of cell protein to concentrations more than 40-fold greater (Figure 2 ). Increasing the time of exposure to CF, which is expected to increase CF load in continuously endocytosing cells, produced corresponding increases in endogenous ferritin concentrations (Figure 2A) . Similarly the CF-induced increase in endogenous ferritin was dose dependent ( Figure 2B ). Ferritin levels remained elevated for several days. The gradual decrease in ferritin concentration after 8 h in Figure 2 (B) is due to increasing cell density as measured by increasing cell protein concentrations, supporting the hypothesis that the CF iron is available for cell metabolism.
The increased ferritin levels measured in Figure 2 were shown to be endogenous and not merely a by-product of CF internalization, as cells showed a time-dependent decrease in horse spleen ferritin levels concomitant with the RIA-measured increase in endogenous ferritin (Figure 3 ). Cells not incubated with CF showed neither horse-spleen ferritin nor increased endogenous
Figure 1 RIA assay is specific for human ferritin
Human ferritin, horse spleen ferritin or CF was tested in the RIA assay at the indicated concentrations. The values given (meanspS.E.M., n l 2) represent the amount of radioactive antibody bound to the washed beads.
Figure 2 Response of endogenous ferritin levels to incubation with cationic ferritin
(A) Time-dependent CF-induced ferritin synthesis. Cells were pulsed for the indicated durations with 10 µg/ml CF and were then washed and incubated in growth medium for the designated durations. Cells were lysed ; endogenous ferritin levels were measured by RIA. (B) Dosedependent induction of ferritin synthesis. Cells were pulsed for 1 h with various concentrations of CF, then washed and incubated in growth medium for the designated durations. Cells were lysed ; endogenous ferritin levels were measured by RIA. The values given (meanspS.E.M., n l 2) are corrected for total cellular protein levels.
ferritin. The observed increase in cellular ferritin levels was shown not to result from iron uptake at the cell surface, as the time-dependent increase in endogenous ferritin found in CFtreated cells was unaffected by co-incubation with either the impermeant ferrous chelator BPS (2 mM) or 2 mg\ml conalbumin, an impermeant ferric chelator that does not bind to human transferrin receptors (results not shown). Taken together, these results support the hypothesis that the increase in endogenous ferritin after treatment with CF results from lysosomal iron released intracellularly.
Ferritin turnover is not affected by ferritin concentration
We next wished to investigate the mechanism by which cells recycle endogenous ferritin from the cytoplasm to the lysosome. A specific mechanism for ferritin transfer from the cytoplasm to the lysosome might be expected to be saturable, and cells with greatly increased intracellular ferritin levels might have decreased ferritin turnover rates. Alternatively, if ferritin lysosomal autophagy occurs by a non-specific mechanism, it might be expected that ferritin turnover would be independent of basal ferritin
Figure 5 Effect of incubation with ascorbate on ferritin synthesis and turnover
(A) RIA measurement of endogenous ferritin synthesis in response to incubation with CF. Cells were incubated with 10 µg/ml CF in growth medium for 4 h, then washed and incubated in growth medium. The ascorbate concentrations shown were maintained throughout the experiment. At designated times, cells were lysed and analysed by RIA. The values given (meanspS.E.M., n l 2) are corrected for total cellular protein levels. (B) Degradation of endogenous ferritin. Cells were incubated with CF, in the absence or presence of ascorbate, to produce steady-state ferritin levels. Metabolic labelling was then performed as described in the legend to Figure 4 . Results (meanspS.E.M., n l 4) were normalized to band intensities at zero time.
levels. These hypotheses can be distinguished by measuring endogenous ferritin turnover rates in cell populations containing a range of ferritin concentrations. For these experiments, cells were incubated with CF for various durations ; the CF was then removed and the cells were subsequently incubated in growth medium until RIA analysis indicated that endogenous ferritin levels had stabilized. The degradation of endogenous ferritin was then determined by a metabolic labelling experiment. We determined that the degradation rate was not substantially altered over a 20-fold range in cellular ferritin levels (Figure 4 ). This result suggests that ferritin lysosomal autophagy and subsequent ferritin degradation could occur by a non-specific, or at least a non-saturable, mechanism.
Studies have suggested that the release of ferritin iron occurs in the cytosol [4] . Evidence that supports this hypothesis is that addition of ascorbate to the culture medium increased ferritin iron egress and inhibited the movement of ferritin to the lysosome. We investigated the effect of ascorbate on ferritin metabolism in HF cells incubated with CF ( Figure 5 ). Increases in endogenous ferritin levels in response to incubation with CF were found to be accelerated when cells were grown in medium supplemented with ascorbate ( Figure 5A ). Thus ascorbate stimulates increased ferritin levels even if the source of ferritin iron is lysosomal. Furthermore a decreased turnover of endogenous ferritin was also observed when cells with elevated endogenous ferritin levels were incubated in the presence of ascorbate ( Figure 5B ). This suggests that increases in ferritin levels found in ascorbatetreated cells might be partly attributable to decreased turnover rates.
Degradation of ferritin in intact lysosomes
Our turnover studies did not provide firm evidence that endogenous ferritin is being degraded in the lysosome, as opposed to cytosolic degradation. To show that ferritin could be degraded in lysosomes, we isolated lysosomes containing endogenous ferritin and measured degradation in itro. Untreated cells were Dounce-homogenized ; lysates were centrifuged on a Percoll gradient, then fractionated. The location of lysosomes in the gradient was determined with a hexosaminidase assay [12] . Lysosomes were found in the bottom three fractions (Figure 6 ). The content of endogenous ferritin in each fraction was determined by RIA. Most ferritin was localized to vacuolar fractions ( Figure 6 ). For the large-scale isolation of lysosomes, cells were incubated with CF, then grown to generate high levels of endogenous ferritin. After cellular ferritin levels had stabilized, cells were Dounce-homogenized, then centrifuged on Percoll gradients. Fractions were assayed for hexosaminidase ; those containing high levels of lysosomal enzymes were pooled and lysosomes were pelleted then resuspended in STE buffer. Lysosomal ferritin degradation in itro was found to be both time-and temperature-dependent and was accelerated in the presence of ATP ( Figure 7A ). The observed acceleration of degradation in the presence of ATP was also temperaturedependent, as incubation at 0 mC blocked degradation in both the presence and the absence of ATP ( Figure 7B ). We consistently observed that 30-50 % of the isolated lysosomal ferritin was not degraded, regardless of the duration of incubation. The reason for this is unclear. This undegradable ferritin might be in the form of haemosiderin, an insoluble form of ferritin found under conditions of iron excess [1] . Alternatively it might be that some cytosolic ferritin is isolated along with lysosomes, or that the pelleting and resuspension involved in lysosomal isolation resulted in broken or otherwise inactive lysosomes. Furthermore lysosomal pH might not have been maintained during the incubation, or some lysosomal proteolytic enzymes might have been exhausted under our observation conditions.
DISCUSSION
We have found that CF can be used to create greatly elevated basal ferritin levels in fibroblasts. This demonstrates that ferritin molecules can be degraded in the lysosome and that the released iron can be transported across the lysosomal membrane to stimulate the production of new ferritin molecules. It might also be that CF stimulation results in decreased degradation and that this effect also contributes to increased ferritin levels. We also found that increases in basal ferritin do not affect the ferritin half-life in i o. This suggests that ferritin degradation occurs by a non-specific or non-saturable mechanism, although we cannot rule out the possibility that a specific transport mechanism exists that was not saturated by the increased cytosolic ferritin levels. Further, lysosomal degradation of endogenous ferritin in itro occurs in a time-and temperature-dependent manner, with an increased rate of degradation observed in itro when an ATPregenerating system is present. We believe that our results are consistent with a model in which cytosolic ferritin is taken into the lysosomes and degraded, and solubilized iron from the ferric core is transported across the lysosomal membrane back into the cytosol. This model might be a general route for recycling metals. Rather than requiring specific mechanisms for removing metals from each individual metalloprotein, the proteins could be taken to the lysosome and degraded, and the metals could then be reintroduced into the cytosol for reuse.
Our results also imply the regulation of lysosomal iron efflux, as increasing doses of CF produce more sustained ferritin synthesis rather than more rapid ferritin synthesis, a result consistent with a model in which lysosomal ferritin is rapidly degraded, but that the resultant soluble iron is transported into the cytosol at a fixed rate. This interpretation implies that lysosomes might be able to store soluble iron. This notion is attractive because free iron in the cytosol is potentially dangerous, and sequestration of soluble iron in the lysosome might help protect the cell from damage due to the generation of toxic free radicals.
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